More Weight Loss Solutions

Archives

Archive for the ‘Testosterone’ Category

Men are often portrayed as wanting to have sex all the time. In reality, a sluggish sex drive is something many men deal with at some point in their lives.

Several studies, including the often-cited Massachusetts Male Ageing Study from the University of Boston (conducted between 1987 and 1989), suggest erectile dysfunction affects more than half of all men to some degree, and is more prevalent in older men.

A low libido does not just take a toll on a man's emotional well-being; it can affect his partner and relationship, too, says Dr Angela Tan, a Singapore-based family doctor and intimacy coach.

"For starters, your male partner may feel that he is not satisfying you, and this may make him feel inadequate. It may also affect his identity and how he sees himself as a man. And if your once fulfilling sex life is now non-existent or no longer making you happy, you may wonder if [he] is attracted to you any more. This may create problems like anger and resentment, and may even lead to arguments and affairs later."

To help your partner and prevent misunderstandings, it is useful to know what may be affecting his libido.

According to Dr Colin Teo Chang Peng, a urologist at Colin Teo Urology in Singapore, one of the top causes of a low libido in men is low testosterone.

This is sometimes referred to as andropause or male "manopause", testosterone deficiency syndrome (TDS) or late onset hypogonadism (LOH).

"A man's testosterone levels start to decrease at a rate of about one per cent to two per cent every year from the age of 40," Teo explains.

"While testosterone is essential to sexual health and libido, it is also a metabolic hormone that has an effect on a man's blood-sugar control, cardiac health, psychological well-being, motivational drive, memory and physical fitness."

Low testosterone is also commonly linked with other medical conditions such as diabetes, hypertension, metabolic syndrome, coronary heart disease, obesity and renal failure, he adds.

An online survey of more than 5,000 men revealed that male sexual desire is complex and cannot be reduced to a single equation.

The researchers behind the European survey found that low confidence in their ability to achieve and maintain an erection, a lack of attraction to their partner, and being in a long-term relationship were some of the factors associated with the respondents' low sex drive. The results were published in 2014 in medical journal The Journal of Sexual Medicine.

There may be other reasons your partner cannot get in the mood for sex. Tan says that these may be medical - brain conditions like stroke, for instance; conditions that require chemotherapy, like cancer, which may deflate him emotionally; and liver problems that can cause hormonal issues.

Depression and anxiety disorder are also known to be mood killers.

If your partner is on medication, for instance some types of antidepressants and antipsychotics, he may experience a low libido, too. Even alcohol can decrease his sexual desire.

"Other causes may be related to your man's lifestyle - he may be stressed at work or under financial stress, for example; or perhaps his relationship with you feels strained, and that is affecting his desire to have sex with you," Tan says.

"Some men also have certain cultural or religious beliefs and values that may influence their views on sex, which may in turn dampen their libido."

Many men feel uneasy discussing their lack of sexual desire, especially in Asian societies, where talking about sex is considered taboo. However, Teo believes that this is slowly changing, with more men seeking their doctors' advice.

"The culture seems to be a bit more open now," he says. "More patients and doctors are aware that many sexual problems are also medical conditions. They also know that these conditions can be treated safely and effectively. We do see more men consulting their doctors about low libido and other andropause symptoms like lethargy, and many of these patients are accompanied by their partners."

The men who seek Teo's advice as soon as they notice symptoms tend to be in their 40s and 50s, leading fast-paced lives at or near the peak of their careers. A decline in their work, fitness or sexual performance is usually what motivates them to look for solutions to help restore their quality of life.

Patients who do not have fast-paced, active or career-driven lives may not notice the effects of andropause straight away and often take a while to ask their doctor for help.

It is not easy broaching the subject of low sex drive with your man, but you should not sweep the issue under the carpet, either. Tan suggests communicating your concerns in a calm, positive and non-threatening manner.

"Communication is key in this kind of situation," Tan says. "You want to be honest but not rude, and what you should not do is blame your partner or yourself, as this can have a detrimental effect on your relationship as well as your and your man's emotional well-being."

Tan advises couples to get professional help to determine the cause of a man's low sex drive and then explore ways to solve it together.

In the meantime, she says it is still possible to be intimate and maintain your physical and emotional connection, by cuddling and engaging in oral sex. Your man can also satisfy you using sex toys.

Fortunately, there are many solutions to help men get their sex lives back on track. Teo says that when a patient complains about andropause symptoms and his testosterone levels are found to be below normal, he is diagnosed with TDS and advised to begin testosterone replacement therapy (TRT).

Safe and effective, this treatment can be delivered orally with capsules, through the skin with daily gel applications, or as an injection every three months.

If the patient also has a chronic medical condition, he will be advised to undergo treatment for it, as the condition may impact his libido.

"Once testosterone levels are restored, other sexual dysfunctions can be actively remedied," says Teo. "These include erectile dysfunction, which can be treated with erectogenic medications in the form of oral tablets, injectables, and the recently available low-intensity shock wave therapy [LIST]."

In LIST, a wand-like device delivers mild shock waves to the penis that assists in the growth of new blood vessels.

Teo adds that, for patients with premature ejaculation, oral medications can help, giving the patient better control and helping the couple achieve satisfaction during sex.

In cases that do not respond to drugs or other therapies, penile implant surgery is a popular option.

A holistic approach is key when addressing low libido, so it may be necessary to include other forms of treatment, such as psychotherapy and couples' counselling.

Ultimately, while all forms of sexual dysfunction can be treated, Teo says a healthy lifestyle goes a long way towards helping men enjoy a satisfying sexual relationship.

"Exercising regularly relaxes the body and triggers the release of feel-good chemicals called endorphins, which boost your emotional well-being, while eating wholesome foods can counter some of the symptoms of andropause. You should also keep any chronic medical conditions in check and work towards strengthening your relationship with your partner."

This article was first published inSouth China Morning Post.

See the original post here:
Erectile dysfunction: When he's (not) in the mood for love - AsiaOne

Comments Off on Erectile dysfunction: When he’s (not) in the mood for love – AsiaOne
Dec 4th, 2019 | Filed under Testosterone

Click here to read the full article.

Over a long career that stretches back 25 years, stuntman and stunt coordinator-turned-second-unit-director and actor Darrin Prescott has choreographed many a spectacular car chase and race in such testosterone-fueled movies as Drive, Deadpool 2, Baby Driver and The Bourne Ultimatum, which won him a Screen Actors Guild award as part of the stunt ensemble.

But when director James Mangold called him up to play famous racer Bob Bondurant and supervise the second-unit action crew for Ford v Ferrari, he knew itd be a special job.

More from Variety

He loved what wed done on Baby Driver, and when I asked him how we were going to handle all the classic race cars on this, he just said, Were going to build em, Prescott says.

This was music to Prescotts ears, as Ford v Ferrari chronicles the story of race car legends Carroll Shelby (Matt Damon) and Ken Miles (Christian Bale) and culminates in the historic showdown between the Ford Motor Co. and legendary Ferrari at the grueling 1966 24-hour Le Mans race in France. Those cars are now priceless museum pieces, so high-performance replicas had to be built.

We rarely get the opportunity to build cars like these, Prescott says. Usually, when I get a call like this, they always have big eyes. They always tell you theres going to be McLarens and Lamborghinis, and ultimately you end up with Corvettes and some sort of product placement. But they actually pulled it off and delivered this time.

Coupled with Mangolds determination to use real cars was his plan to re-create and shoot the famous Le Mans race all in camera, rather than using CGI, says Prescott. That presented quite a few big challenges. The first and biggest was that the original Le Mans course doesnt exist anymore or at least, nothing like it used to be.

The filmmakers used several locations in Georgia to double for Le Mans in the films climactic sequence, which lasts some 40 minutes. So we had to tie all those locations together to make it all as seamless as possible, he says. And then Jim wanted to make sure we maintained an authentic camera style. He didnt want any big swooping camera moves and any hint of the beauty shot approach you see in all the car commercials. And because the cars were exact period replicas, there was very little room to mount cameras and roll cages in them.

With all the restrictions, Prescott and his core team, which included stunt coordinators Robert Nagle and Jeremy Fry (also a driver), focused on sheer speed and storytelling. Every shot had a purpose, and sometimes on second unit and with action its easy to forget all that, he says. But Jim was adamant about that, more so than anyone else Ive ever worked with.

Prescott shot wide-angle anamorphic for eight weeks using a team of a dozen professional drivers, some of whom had actually won Le Mans, he says. With the anamorphic lenses, we had to cram the cars right up into the lens maybe just six inches from camera, which you can only achieve with drivers of that caliber. On top of that, the cars are so close to each other and theyd be doing 140 mph with the camera car inches off their nose. But the truth is, they actually had to dumb it down. It was nothing to these guys as theyre used to going 200 mph.But few crew members were used to racing in the sweltering heat and humidity of a Georgia summer. They had to wear these special, iced cool suits, as the track pavement temperature was 140 degrees, Prescott says. That was almost the hardest part of the whole shoot.

Best of Variety

Sign up for Varietys Newsletter. For the latest news, follow us on Facebook, Twitter, and Instagram.

Read more here:
Ford v Ferrari Race Re-Creations Better Than The Real Thing - Yahoo Entertainment

Comments Off on Ford v Ferrari Race Re-Creations Better Than The Real Thing – Yahoo Entertainment
Dec 4th, 2019 | Filed under Testosterone

The global market for testosterone replacement therapy is characterized by the presence of a large number of small and large scale manufacturers. All of the manufacturers have been steadfast in filling the meagre market gap in order to enhance their prospects of growth. Furthermore, research and development has been the central characteristic of al the market players operating in the global market. In 2015, it was found that 80% of the total market share was held by the top five market vendors with AbbVie Inc. taking the lead.

Obtain Report Details @https://www.transparencymarketresearch.com/testosterone-replacement-therapy.html

The large scale vendors are focusing on establishing an iconic brand for their product by resorting to rigorous marketing and advertising tactics. The smaller companies are expected to concentrate on capturing the local and regional markets to sustain themselves in the current scenario of stiff competition. A negative implication for the leading market players in recent times has been the loss of patents for their products. This has not only plundered them of revenues but has also affected the workflow of these companies.

The market players are expected to launch awareness campaigns about testosterone replacement therapies in order to educate and inform the consumers. Hence, the market for testosterone replacement therapies is expected to witness the emergence of several new trends and opportunities over the forthcoming years. Some of the key players in the global testosterone replacement therapy market include Bayer AG, Endo Pharmaceuticals, Inc., Novartis AG, and Allergen plc.

Request PDF Sample of Testosterone Replacement Therapy Market Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1097

The CAGR for theglobal testosterone replacement therapy marketis estimated to be -4.20% over the period between 2016 and 2024. The negative growth rate of the global market is expected to take the market value from US2.0 bn in 2015 to a decreased value of US$1.3 bn by 2024-end.

High Incidence of Hypogonadism to Drive Market Demand

Research studies suggest that around 30% of all men suffer from testosterone deficiency, which has driven demand within the global market for testosterone replacement therapy. Furthermore, the population demographic of men in the age range of 40-79 years is more likely to suffer from testosterone deficiency. The need for mutation or having an offspring amongst men in the aforementioned age range has driven demand within the global market.

Moreover, the geriatric population has been on a rise, which underhandedly contributes to market growth. Several campaigns aimed at educating people about the benefits of testosterone replacement therapy have been an important propeller of demand within the global market. It is anticipated that more people suffering from testosterone deficiency would resort to these therapies over the coming years.

Enquiry for Discount on Testosterone Replacement Therapy Market Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1097

Side Effects of Testosterone Replacement Therapy Could Obstruct Market Growth

Despite the rising awareness amongst the masses about the advantages of testosterone replacement therapies, the market growth is hindered by the apprehension of the people. The chances of developing metabolic disorders are higher in men who undergo testosterone replacement therapies.

Furthermore, the risk of developing cardiovascular diseases also discourages people from resorting to testosterone replacement therapies. The FDA has also cautioned people about the use of such therapies by issuing strict warnings, which has further obstructed the growth of the global market.

Read the original here:
Testosterone Replacement Therapy Market to See Admirable Grrowth by 2024 According to a New Research Report - Kentucky Reports

Comments Off on Testosterone Replacement Therapy Market to See Admirable Grrowth by 2024 According to a New Research Report – Kentucky Reports
Dec 3rd, 2019 | Filed under Testosterone

TORONTO Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) today announced that the revised commercial partnership agreement with Aytu Bioscience (Aytu) to accelerate the growth of NATESTO in the United States is now closed and fully effective as of December 1, 2019. Both parties have mutually waived the closing conditions of the revised partnership agreement, including the requirement that Acerus complete a raise of a minimum of USD 10 million on or before the end of January 2020, enabling Acerus to launch a U.S.-based specialty sales force, which will promote NATESTO to urologists and endocrinologists. Aytu will continue to book all NATESTO revenue in the United States and they will promote NATESTO to all other specialties including internal medicine and family practice.

To accelerate the launch of Acerus U.S. commercial team, Aytu has agreed to transfer 5 current sales personnel to Acerus as of December 2, 2019. These staff will operate as Acerus employees but they will remain on Aytus payroll until the earlier of the date on which Acerus is ready to fully assume the personnel or June 30, 2020. Aytu will deduct the costs of these sales personnel from quarterly payments otherwise owed to Acerus under the revised agreement, with a final accounting to be done once per year. Throughout 2020, Acerus will be building out a complete US-based specialty care sales force and other commercial functions, significantly increasing the number of employees working directly on NATESTO in the United States.

This co-promotion is expected to significantly increase sales force coverage of targeted U.S. prescribers, putting a higher promotional focus on urologists and endocrinologists, while enabling Aytu to focus its promotional efforts in primary care and other specialties.

Acerus is extremely pleased to see our revised partnership with Aytu moving to execution mode as we strongly believe that the performance of NATESTO in the U.S. will benefit from an enhanced commercial focus on urology and endocrinology, said Ed Gudaitis, President and Chief Executive Officer of Acerus. We are happy to welcome the former Aytu staff to the Acerus team. With this revised partnership, Acerus is effectively pivoting its focus of effort to the U.S. NATESTO opportunity. As such, we have implemented a resource reallocation program within our Canadian office that has led to a greater than 50% reduction in headcount so that we can align our SG&A spend appropriately.

On July 29, 2019 the companies agreed to expand their commercial partnership and amend and restate the original 2016 NATESTO exclusive U.S. license agreement. Under the terms of the new agreement, Aytu returns the NDA for NATESTO in the U.S. back to Acerus. Going forward Acerus will assume all regulatory and clinical responsibilities and costs for the product in the U.S. Acerus will take on a more expansive role in matters such as U.S. marketing, reimbursement and medical strategy as part of the companies joint commercialization committee, and will launch a specialist sales force focused on urologists and endocrinologists (Acerus Sales Channel). Aytu will retain its primary care sales force (Aytu Sales Channel) and will continue to book all product net revenue while serving as the exclusive U.S. supplier of NATESTO to wholesalers, pharmacies and other customers that receive a direct shipment. Financial payments will be based upon a tiered level of net revenue, post cost of goods sold (COGS), based on annual sales performance in the respective Acerus and Aytu Sales Channels.

To establish a high performing commercial footprint in the U.S., Acerus has engaged Syneos Health (NASDAQ: SYNH), a leading integrated biopharmaceutical solutions organization including the industrys largest Contract Commercial Organization (CCO), to be its commercialization partner. Syneos Health has extensive experience in Mens Health and with NATESTO, and offers an end-to-end model that will enable Acerus to rapidly stand up a U.S. commercial team; to scale across all aspects of commercialization, including medical and regulatory affairs, managed markets, marketing and sales; and will provide greater flexibility and effectiveness in resource deployment.

Low testosterone is estimated to affect approximately 39% of men over 45 years old in the U.S.; however, because the condition is underdiagnosed the overall prevalence is uncertain1. While patients have access to other treatment options, NATESTO is unique in that it is administered in seconds via a convenient and simple nasal gel applicator, addressing the risk of testosterone transference associated with other topical products, which carry black box warnings on their product labels.

About NATESTO (Testosterone) Nasal Gel

NATESTO is a nasal gel formulation of testosterone developed by Acerus Pharmaceutical Corporation and indicated as a replacement therapy for men diagnosed with conditions associated with a deficiency or absence of endogenous testosterone (hypogonadism). It is the first and only nasally-administered testosterone product approved by the U.S. Food and Drug Administration, Health Canada and South Korea Ministry of Food and Drug Safety (MFDS), available in a no-touch dispenser with a metered dose pump. A copy of the NATESTO Canadian product monograph can be found at: http://www.aceruspharma.com/English/products-and-pipeline/NATESTO /default.aspx. For further information, specific to the U.S. product dosing and administration, please visit: http://www.NATESTO .com.

About Acerus

Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient experience, with a primary focus in the field of mens health. The Company commercializes its products via its own salesforce in Canada, and through a global network of licensed distributors in the U.S. and other territories.

Acerus shares trade on TSX under the symbol ASP and on OTCQB under the symbol ASPCF. For more information, visit http://www.aceruspharma.com and follow us on Twitter and LinkedIn.

Notice Regarding Forward-Looking Statements

Information in this press release that is not current or historical factual information may constitute forward looking information within the meaning of securities laws. Implicit in this information are assumptions regarding our future operational results. These assumptions, although considered reasonable by the company at the time of preparation, may prove to be incorrect. Readers are cautioned that actual performance of the company is subject to a number of risks and uncertainties, including with respect to the commercial performance of NATESTO in the United States, and could differ materially from what is currently expected as set out above. For more exhaustive information on these risks and uncertainties you should refer to our annual information form dated March 4, 2019 which is available at http://www.sedar.com. Forward-looking information contained in this press release is based on our current estimates, expectations and projections, which we believe are reasonable as of the current date. You should not place undue importance on forward-looking information and should not rely upon this information as of any other date. While we may elect to, we are under no obligation and do not undertake to update this information at any particular time, whether as a result of new information, future events or otherwise, except as required by applicable securities law.

1 Mulligan T, Frick MF, et al. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006 Jul 1; 60(7): 762769

View source version on businesswire.com: https://www.businesswire.com/news/home/20191202005215/en/

Contacts

Media: Edward Gudaitis President and Chief Executive Officer egudaitis@aceruspharma.com (905) 817-8194

View post:
Expanded U.S. NATETSO Partnership Between Acerus Pharmaceuticals and Aytu BioScience Is Now Fully Operational - Financial Post

Comments Off on Expanded U.S. NATETSO Partnership Between Acerus Pharmaceuticals and Aytu BioScience Is Now Fully Operational – Financial Post
Dec 3rd, 2019 | Filed under Testosterone

Daughters of women with polycystic ovary syndrome, a common disorder that can cause excessive body hair, acne and fertility problems, are five times more likely than the average woman to develop the condition, a major study has found.

Researchers in Sweden examined the medical histories of nearly 30,000 women and their mothers. The records from national registries showed that 3.4% of women born to mothers with PCOS were later diagnosed themselves, compared with only 0.6% of women whose mothers did not have the condition.

The greater risk was confirmed in a smaller study that followed the health of 35 Chilean women from birth to adulthood. Of the 21 women whose mothers had PCOS, 15 met the medical criteria for a PCOS diagnosis. Only one of the mothers without PCOS had a daughter with the disorder.

Our work shows that the daughters of women with PCOS have an increased risk of developing the disorder, said Elisabet Stener-Victorin, who led the work at the Karolinska Institute in Stockholm. This is an under-recognised condition. Many women out there have either diagnosed themselves or are not diagnosed and are not feeling good.

Nearly one in five women of reproductive age in the UK is thought to have PCOS, but many women only find out after several years of medical investigations. Despite its widespread impact on womens health, the causes and risk factors for PCOS are still largely unknown.

The condition is linked to abnormal levels of hormones, in particular high amounts of insulin, the hormone that controls sugar levels. The extra insulin causes the ovaries to overproduce testosterone, which in turn can disrupt the womans periods and make it hard to get pregnant. The condition, which also raises the risk of type 2 diabetes, is exacerbated by obesity.

Previous studies of PCOS suggest that genetics explains only 10% of its heritability. To further understand its drivers, Stener-Victorin ran a series of animal studies. She found that when mice in the late stage of pregnancy had testosterone injections to mimic PCOS, their female mouse pups grew up to have PCOS-like symptoms. The disorder was passed on for up to three generations. The findings suggest that high levels of male sex hormones in the womb, which are brought on by PCOS, are a major factor in passing the condition on.

Writing in Nature Medicine, the scientists describe how they identified four genes that were expressed at abnormal levels in both the mouse eggs and in serum taken from daughters of women with PCOS. If further work confirms the genes role in PCOS, they could potentially form the basis for a screening test in young women, Stener-Victorin said.

It is very important for women with PCOS to be diagnosed and treated, if possible maybe lowering the androgen levels, because it may affect their future children and grandchildren, Stener-Victorin told the Guardian.

Doctors tend to rely on a combination of assessments to diagnose PCOS, such as infrequent periods, high levels of testosterone and ultrasound scans, which can often pick up affected ovaries.

The condition has no cure, but obese people can improve their symptoms by eating a diet rich in fruit and vegetables and reducing their weight. Many women who struggle to conceive because of PCOS are helped with drugs such as clomifene, which can re-establish regular periods, and metformin, a diabetes drug that helps lower insulin in the blood.

This group has done some excellent animal work to understand the mechanisms behind PCOS, but it is too early to extrapolate the findings to humans, said Stephen Franks, professor of reproductive endocrinology at Imperial College, London. There are indications that there are transgenerational effects of PCOS in human offspring, but we need more evidence to fully understand the picture.

The rest is here:
Daughters of women with PCOS face five times greater risk - The Guardian

Comments Off on Daughters of women with PCOS face five times greater risk – The Guardian
Dec 3rd, 2019 | Filed under Testosterone

There should be third sex competitions for them medical expert on female testosterone case Medical expert Dr. Sherif el-Refee, who specializes in disorders of sexual development and hormonal problems, has suggested that athletes with biological irregularities should compete in separate third sex tournaments.

Dr. Sherif, a senior paediatric endocrinologist consultant at Imperial College London Diabetes Center in Abu Dhabi, backs the view of the International Association of Athletics Federations (IAAF) that high testosterone can help professional athletes to enhance their performance.

Talking to RT, Dr. Sherif explained the impact that testosterone has on female athletes, adding that the much-publicized case of South African runner Caster Semenya could trigger an influx of athletes who change their hormone levels to win female competitions.

Disorder of sexual development or what used to be called intersex is very controversial, Dr. Sherif said.

And the more we understand about it, the more confusing it gets. Now we know there are so many conditions that make a person not typically male or not typically female.

We used to think that doing chromosome analyses will solve this problem. However we now know that in rare circumstances some women are actually XY and some men have XX chromosomes.

Dr. Sherif pointed out that testosterone helps to build muscle mass and increase physical strength, which potentially makes the hormone a powerful performance enhancer.

We started to look at the hormone level. We know that men have very high level of testosterone and very low level of estrogen, the female hormone. And women have very low level of testosterone, but very high level of estrogen.

The high level in male subjects of testosterone makes their muscles bulkier and stronger and also makes their bones thicker and actually the angulation of their bone differs from women.

And therefore their performance and physical activity is higher than women. And it is well known that even some men are taking extra testosterone as performance enhancing drugs. Therefore currently we take the testosterone level as an indicator of maleness or femaleness, Dr. Sherif said.

The medical expert stressed that women with a high testosterone level have an unfair advantage over female competitors, suggesting that third sex competitions should be introduced for athletes with biological specifics, such as Semenya.

Would we consider he or she as a man or as a woman? Who can decide this? Can he or she decide this or should authorities decide this based on testosterone level?And if somebody has a high testosterone level, the argument is why dont they compete with men rather than competing with women?

Therefore it seems unfair to allow a woman with a male level of testosterone to compete with women. Because this will open a flood of athletes who can change their hormone level and compete with women.

Perhaps the way out is to establish a separate third sex competition. This is purely my medical point of view, but obviously there is other consideration which should be taken by (sports) authorities, Dr. Sherif concluded.

Two-time Olympic champion Semenya is currently attempting to overturn new IAAF regulation which requires athletes with high testosterone to reduce the hormone level. The South African runner insists that her elevated testosterone is a biological specific she has had from birth.

More:
'There should be third sex competitions for them' medical expert on female testosterone case - Stock Daily Dish

Comments Off on ‘There should be third sex competitions for them’ medical expert on female testosterone case – Stock Daily Dish
Dec 2nd, 2019 | Filed under Testosterone

CultureArtsOf all the groups you probably wouldnt want to be part of, the hyper-adrenalised, hardscrabble populace of Jordan Belfort's memoir is one

Friday, 29th November 2019, 4:44 pm

The Wolf of Wall Street Immersive Experience, Sun Street, London,

Of all the groups you probably wouldnt want to be part of, surely the hyper-adrenalised, hardscrabble populace of The Wolf of Wall Street, the Jordan Belfort memoir made into an amphetamine rush of a film by Martin Scorsese in 2013, must rank near the very top. And yet here, against expectation, is an immersive theatre adaptation. Whats more, it is being staged just a coke-fuelled trot from Londons City equivalent of the do-or-die New York milieu from which Belfort has since emerged, post-imprisonment, as some sort of anti-heroic guru.

And if your response to the very fact of this show is, Why?, well, join the club. Whereas writer-director Alexander Wright hit paydirt with an ongoing, comparably immersive Great Gatsby, a story that allows for lots of fancy-dress shenanigans, whats the appeal of losing the celluloid filter between us and Jordan and his money-mad acolytes? Not long into the (overlong) scenario, I had a puzzling sense of dj vu until I realised that I hadnt experienced such barely contained testosterone since I found myself some years back on a flight to Prague with a stag party. (The same group was virtually comatose on the flight back.)

Theres little chance of nodding off here once events indoctrinate us into the code of omert (mispronounced, by the way) at the stock-trading firm of Stratton Oakmont, where Belfort made his fortune before his fall from grace. Asked to drop to our knees (at which point, cue any number of unprintable follow-ons), we then pursue one of several different storylines, or tracks, across 27 rooms watched over by various minders in case things get a bit too, um, frisky. New York-style hot dogs are on sale to ramp up an authenticity not always evident in the wearisomely Goodfellas-esque accents.

I ended up pursuing the domestic narrative, which meant making the acquaintance of the amiable Rhiannon Harper-Raffertys Nadine, wife to Oliver Tilneys hardworking but strangely absent Jordan and mother to their seven-year-old daughter Chandler, played at the performance by the adorable, apparently unfazed Suri De Jesus: one assumes she isnt within earshot when her onstage mum is described as having a delectable vagina.

Lest proceedings be seen to be too in love with a monstrous world from which most of us would run a mile, my fellow playgoers were given a moralistic, virtue-signalling finish that may or may not find an equivalent in the other stories going on elsewhere in the building. At the end, you can grab a drink and mingle with the very lovely cast: the actors I met seemed lightyears removed from the venal environs they must inhabit seven times a week, and praise be for that. THEARTSDESK.COM

See the original post:
The Wolf of Wall Street Immersive Experience, review: an overlong scenario with the barely contained testosterone of a stag party - inews

Comments Off on The Wolf of Wall Street Immersive Experience, review: an overlong scenario with the barely contained testosterone of a stag party – inews
Dec 2nd, 2019 | Filed under Testosterone

For some time now I have watched the immensely popular HGTV as a window on the culturea large picture window letting in lots of natural light, as the rather silly and predictable house hunters are fond of sayingproviding a cameo on the conventions of middle-class society. One notices, with few exceptions, that the wives tend to be voluble and bossy; they speak first, far more often, more insistently and more authoritatively. Their needs and desires are clearly predominant. The husbands, for their part, are mostly bland and subservient, almost leguminous in comparison, generally deferring to their wives with only the occasional mewl of protest.

One notes, too, the lack of genuine taste, the utter preoccupation with trivialities, and the cloying banality of conversation among the often obese participants. They are obviously hewing to script, but the ideas, habits, physical attributes, speech patterns, attitudes and expectations on display are close enough to the cultural norm to seem authentic. People recognize themselves and their aspirations in these TV episodes. Although the self-indulgence and broadly decorticate behavior one observes is certainly off-putting, the absence of gender parity, in favor of the wives, is perhaps the most conspicuous quality that affirms itself.

One might dismiss these observations as making too much of a mere reality TV show, but HGTV does let in a lot of natural light on a culture grown flaccid and critically disoriented. The ascendancy of the now-dominant, rule-giving female and the attendant decline of the proud and assertive male is the order of the day. The male essence is not a privilege but a fact of naturethat is, when nature is allowed to take its course. Yet, everywhere we look men are surrendering their right to be mento be strong, confident, honest, unashamed and productive. I do not blame the vindictive and self-righteous feminists for the debacle. I blame the men who have allowed a social disaster to come to pass. We now see the gradual disappearance, or at least the alarming paucity, of alpha males in the social mix accompanied by the rising tide of beta malesapologists for their toxic nature, Michael Kimmel types who are complicit with the feminist agenda.

In an important talk delivered at the ICMI conference held in Chicago in October 2019, the video of which is soon to be released, former vice-chair of the Maryland Commission for Mens Health Tom Golden pointed out that testosterone levels are markedly declining among Western males. As is well known, testosterone is a male sex hormone that stimulates the production of sperm and the growth of muscle mass. But it is less well known that testosterone is also genetically engineered for status-seeking. University of Zurich neuroscientist Christoph Eisenegger in a major research paper, The role of testosterone in social interaction, suggests that testosterone might be best conceptualized as bringing motives for social status to the fore. Eisenegger showed that those who maintain that high level of testosterone lead only to corruption, aggression and emotional sterility have not adequately considered the evidence; such studies have been clearly refuted. Testosterone is the chemical engine for risk-taking, reciprocity, generosity and competitiveness.

Writing in Forbes, Neil Howe alludes to several analytic reports showing that mens testosterone levels have been declining for decades. Among the many complex factors involved in the downward trend, a crucial element seems to hinge on dismantling age-old ideas about masculinity and triggering real anxiety over changing gender roles. There is no doubt that the economy is shifting away from jobs that favor men [and] toward sectors dominated by women. Howe is plainly a man of leftist sympathiesDonald Trump is old-fashioned, overtly macho, plenty of testosterone there. Nonetheless, while admitting that he might prefer a less testosterone-laden world [which] might be less aggressive and more emotionally expressiveas Eisenegger indicates, a thoroughly mistaken notionHowe remains concerned that America, a once pro-testosterone nation: restless, striving, and rowdyis losing the dynamism, mobility, and enterprise that made it special.

In other words, testosterone is an alpha hormone. When men strive not to excel and triumph but to conform and acquiesce, to blend in safely with majority sentiment, to not rock the boat (even if it is leaking), to go along in order to get along, and to accept the deformed image of masculinity with which they are daily bombarded, it is a sign that the testosterone pool is drying up, as Tom Golden fears and research has borne out. What is cause and what is effect is an open question. Has testosterone declined in response to a changed world, asks Howe, or has the world changed to accommodate less virile men? Or is it both? Whatever the answer, the result is the emergence of the beta man.

Of course, I am using the Greek alphabet somewhat loosely. Status is to a large degree context-dependent and social prestige may not arise exclusively from the alpha hierarchy. But the distinction between alpha and beta, despite the many shades of gray between them, is a useful one and one that is commonly understood. As psychologist Scott Kaufmaninforms us, The most attractive male is really a blend of characteristics, including assertiveness, kindness, cultivated skills and a genuine sense of value in this world. The true alpha is fuller, deeper, and richer. It follows that the true beta is emptier, shallower, and poorer.

Ive had occasion to write in a previous article about the posturing feminist firebrand, Mona Eltahawy, who urges the weekly killingshe calls it cullingof men. Eltahawy cites a local instance of her determination to resist the patriarchy and her fierce courage in fighting it, referring to an episode in a Montreal club in which she physically beat up a man who groped her. I am willing to bet the story is apocryphal. Yet her fable limns a social truth, if only metaphorically, for the straw man in Eltahawys fevered imagination is the fictive representative of the actual beta male who has permitted, and even abetted and cultivated, the travesty of his unmanning. Though exacerbated and more than ever extensive, this development is by no means a novel phenomenon. It has its history.

.

As far back as 1913, E. Belfort Bax in The Fraud of Feminism framed the issue with his characteristic insight and precision. He is worth quoting at length. In any conflict of interest between a man and a woman, he writes, male public opinionsides with the woman, and glories in doing so. Bax finds himself baffled by the intense hatred which the large section of men seem to entertain toward their fellow-malesand their eagerness to champion the female in the sex war. It is undeniable, he continues, that the Womans Movement, unassisted by a solid phalanx of the manhood of any country, could not possibly make any headway. The members of the phalanxlegislators, judges, parsons, magistratesall vie with one another in denouncing the villainy and baseness of the male personTo these are joined a host of literary men and journalistswho contribute their quota to the stream of antimanismthe design of which is to paint man as a base, contemptible creature. Thus the anti-man cultus has been made to flourish [with] the whole of the judiciary and magistracy acting as its priests and ministrants. Plus a change, plus c'est la mme chose. Bax could have been writing at this very moment.

These men may have acted from motives of chivalry or principles of moral virtue. They were not necessarily weaklings or beta males, but the consequences of their actions led to a dilution of the male spirit and temper and to the formation of a class of sexual herbivores who took the path of least resistance. They are our contemporaries, men who may believe they act from high ethical considerations but in reality are feminized creatures who have sold their masculine birthright for a mess of saccharine pottage. In short, they are beta-men. Men seem to be so cowed that they can't fight back, said former feminist Doris Lessing at the 2001 Edinburgh Book Festival. And she was right.

As poet Robert Bly writes in his 1990 bestseller Iron John, begging forgiveness for being a man, in violation of natural male vigor and energy, is a form of psychological suicide. It is a function, says Bly, of male navet, increasingly prominent in the modern era. We see more and more passivity in men, he writes, but also more and more navet. The nave man feels a pride in being attacked. If his wife or girlfriend, furious, shouts that he is a chauvinist, a sexist, a man, he doesnt fight back, but just takes it. In fact, he will offer to carry a womans pain before he checks with his own heart to see if this labor is proper in the situationHe rarely fights for what is his; he gives away his eggs, and other people raise the chicks. (Italics mine.)

In Blys analysis of the Western tragedy pitting the sexes against one another, Powerful sociological and religious forces have acted in the West to favor the trimmed, the sleek, the cerebral, the noninstinctive, and the baldBaxs judges and magistrateswho are the progenitors of the beta men we see all about us today. The beta man is the source of the cultural decrepitude and social dysfunction brought about by the feminist assault on the psychic and biological boundaries that differentiate the sexes. Beta men are committed to resisting what they regard as their raw and turbulent masculinity. They believe that masculinity as historically conceived and as feminists insist is demonic.

For Bly, the antidote to this febrile declension is the Wild Man of myth and folklorepagan, classic, Celticwho has been injured in his sexuality and who must return in all his strength, in touch with God and sexuality, with spirit and earth, that is to say, with himself. A man must rediscover his Zeus energy. And this not only for his own sake but for the sake of woman as well, whose fecund and magnanimous nature has suffered tremendously, as a consequence not only of her own resentments and illusions but also of the favonian influence of compliant men. The goddess Aphrodite, as he puts it, alive inside the female body, is insulted day after day. Regrettably, the Wild Man, or his contemporary avatar the alpha male, whom the mateless woman and the disaffected feminist secretly crave, is very much a minority species. (Interestingly, Neil Howe recognizes that Millennial women yearn for guys who can man up and take care of business, but there are not enough of them around.)

Bly has been mocked by critics who find his thesis one-sided, expressing a return to the primitive, and risibly phallocentric, a reproof that many would apply to cult hero and magister Jordan Peterson. There is much misunderstanding in this position, for Bly accentuates the virtues of male sobriety and duty and Peterson those of competence and responsibility. In his recently published 12 Rules for Life, Peterson, with his considerable authority as a renowned clinical psychologist and an erudite thinker, elaborates the argument for the retrieval of healthy masculinity in a feminist age.

Following psychoanalytical pioneers C.G. Jung and Erich Neumann, Peterson points out that consciousness, always symbolically masculine, even in womenis constantly tempted to sink back down in dependencyand to shed its existential burden. It is aided in that pathological desire by anything that opposes enlightenment, articulation, rationality, self-determination, strength and competencein effect, the beta capitulation to the triumphant female, the renunciation of order and of the Logos by men who have become feminized and submissive.

For such convictions Peterson has been denounced as a muddled thinker, a chauvinist, a huckster, a phallocrat, a misogynist, a fascistyou name it. But Petersons strength and manliness is evident in his ability to soldier on, to rise above such mean-spirited attacks, to lift his voice against the meretricious orthodoxy of the day, and to turn the tables on his detractors, furnishing an example of the alpha sensibility at work.

.

In economist Tyler Cowens terms, America is suffering from a low-hanging fruit mentality. We need high-reachers, innovators, motivators and stubborn achievers to renew a lost momentum; in other words, alpha men. Cowen writes from a leftist perspective, with a hefty dose of social justice theory, and focuses mainly on economic parameters over the last two-to-three centuries. But the concept of making do with low-hanging fruit fits the beta man with a strange perfection. These low-hanging fruit are the ideas, attitudes, compulsions, platitudes and opportunities associated with the feminist movement, which serve the appetite for conformity and approvaluntil, that is, the tree is bare. For a great reckoning is approaching unless we can learn once again to struggle upward where the best fruit can be found.

It is surely time, writes Duncan Smith in The Vast and the Spurious, to redefine the state of gender relations. It is time for some major gaslighting, some alternate ways of viewing social life, to explode the feminist racket and educate its male collaborators. This will be a monumentally difficult task. The beta male (aka the soyboy) is now the Western model of masculinity to be emulated by all right-thinking men. Unfortunately, Nancy Sinatras boots are walking all over him. After all, you keep samin when you oughta be achanginthough, indeed, he is achangin, and at breakneck speed, under the stiletto heels of the Gorgonocracy. The feminist shrew is not the shrew of Shakespeares play; she will not be tamed, for there are precious few Petruchios around to right the balance and equally few Katherines who are meet and amiable.* As Kate says in her concluding speech: I am ashamed that women are so simple/To offer war where they should kneel for peace.

Of course, The Taming of the Shrew is only a play, just as HGTV is a piece of fiction. But the former articulates a longstanding domestic ideal whereas the latter inadvertently discloses a bitter social truth. The house may feature an open concept, three bathrooms, a kitchen island, marble countertops, a tiled backsplash, stainless steel appliances, a butlers pantry and plenty of space to entertain. A profusion of wows, amazings, awesomes, and omigods lard the premises. The man whose great passion in life is outdoor grilling has to settle for indoor sizzling. Happy wife, happy life, goes the adage. But there is no rhyme for husband. In Reality Culture, the wife will keep the house, the kids and the assets if or when she tires of her husband. What to do as the house of Western civilization collapses and the culture self-immolates? Men have to toughen up, says Peterson. And if you think tough men are dangerous, wait until you see what weak men are capable of. And that is something we are seeing with every passing day.

The Western world of discoveries, technologies, amenities and unprecedented wealth, which feminism abuses and exploits to its advantage, is the achievement of an alpha civilization. It is time for the so-called patriarchy to man up and celebrate its creation.

----------------------------

*The Amazon summary of The Taming of the Shrew was obviously written by an academic feminist flogging her ide fixe: have she and Petruchio learned to love each other? Or is the marriage based on terror and deception? As they say, puh-leeze! Shakespeares intent has been clear for centuries, a celebration of traditional male and female roles in matrimony, as exemplified by a self-confident Petruchio and, in the last analysis, a wise, agreeable and spiritually lovely Kate, whose heartfelt eloquence rivals that of Hamlet and Mercutio. They are the truly nuptial couple. It is the countervailing marriages of Petruchios friends Lucentio and Hortensio, whose wives assert their indifference and supremacy, which operate as the shadow alternative. They will not be happy.

The Broadway musical Kiss me Kate is a delightful, updated, slapstick rendition of the theme, a homage to true love redivivus.

---------------------------

David Solways latest book is Notes from a Derelict Culture, Black House Publishing, 2019, London. A CD of his original songs, Partial to Cain, appeared in 2019.

Read more:
Where Have All the Alphas Gone? | Columns - PJ Media

Comments Off on Where Have All the Alphas Gone? | Columns – PJ Media
Dec 1st, 2019 | Filed under Testosterone

Youve been on the pill since high school. Its served its purpose of preventing pregnancy, but do you really know what its done beyond that? You might want to pick up a copy of This Is Your Brain on Birth Control, a new book by Sarah E. Hill, PhD. Dr. Hill is a researcher in evolutionary biology as well as a professor at Texas Christian University.

According to Dr. Hill, although women go on the pill for a few reasons (chief among them pregnancy prevention and clearer skin), sex hormones dont work in such isolated ways. Translation: Sex hormones impact the activities of billions of cells in the body at once, many of which are in the brain. That means playing around with your sex hormones via the birth control pill can influence attraction, sexual motivation, stress, hunger, eating patterns, emotion regulation, friendships, aggression, mood, learning and more. This Is Your Brain on Birth Control seeks to make women aware of everything the pill is doing beyond preventing pregnancy and improving skin.

A few things to note: First, Dr. Hillmakes it very clear that shes completely pro-birthcontrol, and even attributes getting her PhDand having children when she was readytobeing on the pill. She doesnt suggest that women stop taking the pill, nor does she refute the revolutionary effect the pill continues to haveonwomens personal and professional lives. Second, Dr. Hill recognizes that while her book (and much of the research on birth control) is focused on heterosexual cisgender women, shes not discounting the experience of other female-identifying folks who arent on the pill. Read on for three surprising ways being on the pill can affect your life.

RELATED: Which Birth Control Is Right for Me? Every Single Method, Explained

One of the most fascinating points in Dr. Hills book is that the pill can impact the type of partner youre attracted to. Scientists have only recently started to explore this possibility. And although this research is new and the results are mixed, the picture that is beginning to emerge is fascinating. They suggest that the birth control pill might influence everything ranging from whom you pick as your partner to the likelihood that youll get divorced. This can manifest in a number of ways, but it may mean that if youve been on the pill for a long time, find a partner, date that partner for a long time and then go off of the pill, you might see them in a different light once your hormones are responsible for regulating themselves.

Because women on the pill dont ovulate, they dont experience the pre-ovulatory estrogen surge that increases attention to markers of genetic quality in men. What does that mean, exactly? While women who arent on the pill experience a spike in their attraction to men with strong jaws, deep voices and other traditional testosterone markers while their estrogen levels are high (typically mid-cycle), women who are on the pill will probably place less emphasis on sex appeal when choosing a partner.

Considerable research finds that women on the pill have lower sexual desire than what is observed in naturally cycling women. Why? The pill suppresses the hormonal cascade that sets in motion the release of a mature egg. Along with that hormonal cascade comes a surge of estrogen thats known to fuel womens desire for sex. The pill can also cause womens levels of testosterone to steeply decline. (Testosterone plays a role in sexual arousal and responsiveness.) Since a lack of sex drive can be a major source of stress in a womans life and relationship, Dr. Hill suggests being gentle with yourself if you find yourself in this situation. Be patient with yourself and your partner as you work together to troubleshoot your birth control options, she writes. The solution might be as simple as finding a new doctor, a new pill or a different form of birth control.

RELATED: We Ask a Derm: How Do I Go Off Birth Control Without Breaking Out?

View original post here:
The Pill Can Make You Less Attracted to Jerks, and Other Surprising Facts About Birth Control - Yahoo Lifestyle

Comments Off on The Pill Can Make You Less Attracted to Jerks, and Other Surprising Facts About Birth Control – Yahoo Lifestyle
Dec 1st, 2019 | Filed under Testosterone

The Testosterone Replacement Therapy Market report gives an astonishing source to analyze the Testosterone Replacement Therapy market and other fundamental subtleties identifying with it. The examination uncovers the general evaluation and associated ideas of the Testosterone Replacement Therapy market. The report displays a reasonable scenario of the Testosterone Replacement Therapy market, that links applications, proposals, industry chain structure, and definitions. Likewise, it connects the expansive validity of the Testosterone Replacement Therapy market and configurations to a fundamental precision, experiences, and industry-substantiated estimations of the general Testosterone Replacement Therapy market. Additionally, the examination underlines the huge driving business players (AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals) across the globe with clear affiliation profiles, data of the wide-ranging business, item type, conditions, and courses of action.

The Testosterone Replacement Therapy market report more focuses on top industry leaders and explores all essentials facets of competitive landscape. It explains potent business strategies and approaches, consumption propensity, regulatory policies, recent moves taken by competitors, as well as potential investment opportunities and market threats also. The report emphasis crucial financial details of major manufacturers including year-wise sale, revenue growth, CAGR, production cost analysis, and value chain structure.

Interesting? Apply for a sample report: https://www.intenseresearch.com/market-analysis/global-testosterone-replacement-therapy-market-2019-by-manufacturers.html#request-sample

The manufacturing base, Testosterone Replacement Therapy Industry chain view, raw material cost, labor cost, and downstream buyers analysis is represented. The production and market share by type and application from 2019-2025 are presented in this study. Also, the consumption ratio, gross margin analysis, and import-export statistics are portrayed. The market status and SWOT analysis for different regions and countries are profiled in this report.

Global Testosterone Replacement Therapy Market: Type Outlook:Gels, Injections, Patches, Other

Global Testosterone Replacement Therapy Market: Application Outlook:Hospitals, Clinics, Others

North America (United States, Canada)Europe (Germany, France, UK, Italy, Russia, Spain)Asia Pacific (China, Japan, Korea, India, Australia, New Zealand)Middle East & Africa (Middle East, Africa)Latin America (Mexico, Brazil, C. America, Chile, Peru, Colombia)

Furthermore, the report provides the core knowledge of the market by analyzing end users consumption tendency, Testosterone Replacement Therapy market driving factors, ever-changing market dynamics, and rising development patterns in the market.

Besides, the report focuses on the leading contenders in the Testosterone Replacement Therapy industry and delivers an all-inclusive analysis considering their market share, production capacity, value chain analysis, size, sales and distribution network, import/export activities, cost structure, and product specification. Due to the changes in world business policies, it is recommended to be always aware of the facts and data about this market.

The study objectives of this report are:

1) To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).2) To understand the structure of the Testosterone Replacement Therapy market by identifying its various sub-segments.3) The marketing strategies, opportunities, and Testosterone Replacement Therapy development factors are explained.4) The competitive landscape structure, market size estimation, recent advancements in the industry are explained.5) The market dynamics, competition, and complete insights will lead to profitable business plans.6) The pricing structure covering the labor cost, raw material cost, capacity, and supply-demand statistics are presented.

The key dynamic factors that are detailed in the report:

Key Market Dynamics: The Global Testosterone Replacement Therapy Market research report details the latest industry trends, growth patterns, and research methodologies. The factors that directly contribute to the growth of the market include the production strategies and methodologies, development platforms, and the product model itself, wherein a small change would result in further changes in the overall report. All of these factors are explained in detail in the research study.

Market Outlook: The report also sheds light on some of the major factors, including R&D, new product launches, M&A, agreements, partnerships, joint ventures, collaborations, and growth of the key industry participants, on a regional and global basis.

Major Features: The report provides a thorough analysis of some of the significant factors, which include cost, capacity, capacity utilization rate, production, revenue, production rate, consumption, import/export, supply/demand, gross, market share, CAGR, and gross margin. Besides, the report provides a comprehensive study of the key influencing factors and market inclinations, in addition to the relevant market segments and sub-segments.

Analytical Tools: The Global Testosterone Replacement Therapy Market report consists of the precisely studied and evaluated information of the key players and their market scope using several analytical tools, including SWOT analysis, Porters five forces analysis, investment return analysis, and feasibility study. These tools have been used to efficiently study the growth of major industry participants.

Potential Customers: The report offers detailed insights to users, service providers, suppliers, manufacturers, stockholders, and individuals who are interested in evaluating and self-studying this market.

Inquiry for Buying Report: https://www.intenseresearch.com/market-analysis/global-testosterone-replacement-therapy-market-2019-by-manufacturers.html#inquiry-for-buying

Conclusively, the report helps a reader to get an absolute understanding of the Testosterone Replacement Therapy industry through details about the market projection, competitive scenario, industry environment, growth constraining factors, limitations, entry barriers, the provincial regulatory framework as well as upcoming market investment and opportunities, challenges and other growth-promoting factors. This report will provide you a clear view of each and every facet of the market without a need to refer to any other research report or a data source. Our report will provide you with all the facts about the past, present, and future of the concerned Market.

Sorry! The Author has not filled his profile.

Read this article:
Global Testosterone Replacement Therapy Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025 - Daily Industry News Journal

Comments Off on Global Testosterone Replacement Therapy Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025 – Daily Industry News Journal
Nov 28th, 2019 | Filed under Testosterone
Weight Loss Solutions